(Q47269822)

13 January 2018

title

Pegylated interferon-alpha2a kinetics during experimental haemodialysis: impact of permeability and pore size of dialysers (English)

1 reference

13 January 2018

author name string

G Barril

1

1 reference

13 January 2018

J A Quiroga

2

1 reference

13 January 2018

P Sanz

3

1 reference

13 January 2018

F Rodrìguez-Salvanés

4

1 reference

13 January 2018

R Selgas

5

1 reference

13 January 2018

V Carreño

6

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

13 January 2018

Alimentary Pharmacology & Therapeutics

published in

1 reference

13 January 2018

volume

20

1 reference

13 January 2018

issue

1

1 reference

13 January 2018

page(s)

37-44

1 reference

13 January 2018

Properties of membranes used for hemodialysis therapy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Quantification of middle molecular weight solute removal in dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Dissociation between dialysis adequacy and Kt/V.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

A pharmacokinetic model for alpha interferon administered subcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Pegylated interferon-alpha2b: pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data. Hepatitis C Intervention Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Cognition and white matter lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Computational flow modeling in hollow-fiber dialyzers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

Single-dose pharmacokinetics and safety of pegylated interferon-alpha2b in patients with chronic renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02014.X

10.1111/J.1365-2036.2004.02014.X

21 January 2018

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018